The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis; Ono Pharmaceutical
 
Research Funding - Ono Pharmaceutical (Inst)
Comparing the clinical efficacies of anti-PD-1 antibody monotherapy and anti-PD-1 and anti-CTLA-4 combination therapy as first-line immunotherapy in Japanese advanced acral melanoma: A retrospective, multicenter study (JAMP-neo study).
 
Yasuhiro Nakamura
Honoraria - Bristol-Myers Squibb Japan; Kyowa Kirin; Maruho; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Taisho Toyama Pharma
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
 
Yukiko Kiniwa
No Relationships to Disclose
 
Hiroshi Kato
Honoraria - Novartis; Ono Pharmaceutical
 
Osamu Yamasaki
Honoraria - Ono Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst)
 
Takeo Maekawa
Honoraria - Bristol-Myers Squibb Japan; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical
 
Shigeto Matsushita
Honoraria - Kyowa Kirin; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical
 
Tatsuya Takenouchi
No Relationships to Disclose
 
Takashi Inozume
Honoraria - Bristol-Myers Squibb Japan; Merck Sharp & Dohme; Ono Pharmaceutical
 
Yasuo Nakai
No Relationships to Disclose
 
Satoshi Fukushima
No Relationships to Disclose
 
Shintaro Saito
Honoraria - Ono Pharmaceutical
 
Atsushi Otsuka
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical
Research Funding - Eisai (Inst)
 
Noriki Fujimoto
No Relationships to Disclose
 
Taiki Isei
Honoraria - Bristol-Myers Squibb Japan; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical; Pfizer
 
Natsuki Baba
Honoraria - Ono Pharmaceutical
 
Taisuke Matsuya
No Relationships to Disclose
 
Ryo Tanaka
No Relationships to Disclose
 
Takahide Kaneko
No Relationships to Disclose
 
Masazumi Onishi
No Relationships to Disclose
 
Shusuke Yoshikawa
Honoraria - Novartis; Ono Pharmaceutical